NASDAQ: CSBR - Champions Oncology, Inc.

Rentabilidad a seis meses: -8.84%
Sector: Healthcare

Calendario de promoción Champions Oncology, Inc.


Acerca de la empresa

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Más detalles
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Выручка 0.0271
EBITDA 0.000876
Число акций ао 0.01354 млрд
P/E 1001.04
P/S 4.73
P/BV 57.25
EV/EBITDA 142.59
Цена ао 5.02
ISIN US15870P3073
Сайт https://www.championsoncology.com
Валюта usd
IPO date 2003-01-10
Sector Health Care
Industry Life Sciences Tools & Services
Валюта отчета usd
Cambio de precio por día: +0.6652% (4.51)
Cambio de precio por semana.: -5.61% (4.81)
Cambio de precio por mes: +8.51% (4.184)
Cambio de precio en 3 meses.: -10.1% (5.05)
Cambio de precio en seis meses: -8.84% (4.98)
Cambio de precio por año: -26.77% (6.2)
Cambio de precio en 3 años.: -56.76% (10.5)
Cambio de precio en 5 años.: -20.77% (5.73)
Cambio de precio desde principios de año.: -17.6% (5.51)

Subestimación

Nombre Significado Calificación
P/S 1.27 9
P/BV 14.78 1
P/E 197.15 1
EV/EBITDA -48 0
Total: 3.25

Eficiencia

Nombre Significado Calificación
ROA, % -15.55 0
ROE, % -115.08 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -6.16 10
Total: 9.4

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 56.25 7
Rentabilidad Ebitda, % 1540.91 10
Rentabilidad EPS, % 221.98 10
Total: 7.4

ETF Compartir, % Rentabilidad del año, % Dividendos, %
iShares Micro-Cap ETF 0.00839 36.318555985322 1.54048



Supervisor Título profesional Pago año de nacimiento
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (58 años)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (55 años)
Mr. Brady Davis President N/A 1969 (55 años)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

DIRECCIÓN: United States, Hackensack. NJ, One University Plaza - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.championsoncology.com